Radiolabeled prostate specific membrane antigen inhibitors
US9388144B2 · kind B2 · utility
7Cited by
0References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 2014 |
| Grant date | Jul 12, 2016 |
| Priority date | — |
| Expiry date | Jan 7, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F5/003
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds according to Formula I and Formula II are potent inhibitors of PSMA activity:Pharmaceutical compositions may include a complex of a radionuclide and a compound of Formula I or Formula II.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.